This year, i2i launched the third edition of the IP2 Scale Out Program, an international accelerator designed to help promising Taiwanese startups expand into the US market.
On June 20, i2i representatives, alongside two participating Taiwanese startups, Astron Medical and Oen Tech, attended the Taiwan-US SME Forum at the Sheraton LaGuardia East Hotel. The forum focused on exploring collaboration opportunities between Taiwanese and American SMEs and startups.
IP2 Review Board member and Taiwanese-American serial entrepreneur, Terry Hsiao, as well as Po Chen, founder of CancerFree (an alumni of the first cohort of the accelerator), were also present, engaging in key discussions.
For more details about the IP2 Scale Out Program and its achievements, click the link.
Forum Agenda:
Opening Remarks
Ambassador James K.J. Lee, Taipei Economic and Cultural Office in New York
Daniel Krupnick, Assistant Administrator, U.S. Small Business Administration (SBA)
Chia-Ying Wu, Deputy Director General, Small and Medium Enterprise and Startup Administration, Ministry of Economic Affairs (Taiwan)
Featured Presentation
Peter Sexton, Senior International Trade Specialist at the U.S. Department of Commerce, New York Office, provided an overview of SelectUSA and discussed federal and state resources available to help Taiwanese SMEs and startups expand in the US.
Key Discussion 1: Tech Innovation
This session explored collaboration opportunities in the tech innovation space between Taiwanese and American SMEs.
Moderator: John Lynn, COO of WEVE Acceleration, New York
Panelists:
Thomas J. Grech, President, Queens Chamber of Commerce
Gancheng Sun, Director of Business Strategy, Amogy
Terry Hsiao, Taiwanese-American Serial Entrepreneur
Shin Hsiao, CEO, Oen Tech
Key Discussion 2: Biotech & Healthcare
This session focused on exploring partnerships between Taiwanese and American SMEs in the biotech and healthcare sectors.
Moderator: Dr. Po Chen, Founder and CEO, CancerFree
Panelists:
Dr. Chen-Yong Cher, CTO, Graphen Taiwan
Robert Peikwen Cheng, CEO, Yiviva
Dr. Harvey, Chairman, Bluechip International Management Consulting
Tsai, Ilin, COO, Astron Medical
Event Highlights
The forum featured two key discussion panels, where executives from Astron Medical and Oen Tech, both participants in the third edition of the IP2 Scale Out Program, shared the stage with US industry leaders, chambers of commerce, and accelerators. They engaged in in-depth conversations about cross-border collaboration in the fields of tech innovation and biotech, identifying potential partnership opportunities between Taiwan and the US.
Comments